scholarly journals EXTRANODAL DISEASE IS ASSOCIATED WITH SHORTER PROGRESSION‐FREE SURVIVAL AFTER CD19‐CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

2021 ◽  
Vol 39 (S2) ◽  
Author(s):  
V. Bücklein ◽  
V. Blumenberg ◽  
J. Ackermann ◽  
L. Frölich ◽  
M. Winkelmann ◽  
...  
Keyword(s):  
Cell Lymphoma ◽  
Progression Free Survival ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Free Survival ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Extranodal Disease ◽  
Large B Cell

scholarly journals Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss

2019 ◽  
Vol 94 (10) ◽  
Author(s):  
Ali Bukhari ◽  
Firas El Chaer ◽  
Rima Koka ◽  
Zeba Singh ◽  
Elizabeth Hutnick ◽  
...  
Keyword(s):  
Cell Therapy ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Antigen Loss ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document